vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and T1 Energy Inc. (TE). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $210.5M, roughly 1.3× T1 Energy Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -62.0%, a 158.3% gap on every dollar of revenue.
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.
ACAD vs TE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $210.5M |
| Net Profit | $273.6M | $-130.6M |
| Gross Margin | 90.8% | 10.0% |
| Operating Margin | 6.1% | -45.0% |
| Net Margin | 96.3% | -62.0% |
| Revenue YoY | 9.4% | — |
| Net Profit YoY | 90.3% | -375.2% |
| EPS (diluted) | $1.61 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $210.5M | ||
| Q2 25 | $264.6M | $132.8M | ||
| Q1 25 | $244.3M | $53.5M | ||
| Q4 24 | $259.6M | — | ||
| Q3 24 | $250.4M | $0 | ||
| Q2 24 | $242.0M | $0 | ||
| Q1 24 | $205.8M | $0 |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $-130.6M | ||
| Q2 25 | $26.7M | $-31.9M | ||
| Q1 25 | $19.0M | $-16.2M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $-27.5M | ||
| Q2 24 | $33.4M | $-27.0M | ||
| Q1 24 | $16.6M | $-28.5M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | 10.0% | ||
| Q2 25 | 92.2% | 24.7% | ||
| Q1 25 | 91.7% | 33.3% | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | -45.0% | ||
| Q2 25 | 12.2% | -22.0% | ||
| Q1 25 | 7.9% | -44.2% | ||
| Q4 24 | 59.1% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 12.6% | — | ||
| Q1 24 | 7.4% | — |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | -62.0% | ||
| Q2 25 | 10.1% | -24.0% | ||
| Q1 25 | 7.8% | -30.4% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 8.0% | — |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | $-0.87 | ||
| Q2 25 | $0.16 | $-0.21 | ||
| Q1 25 | $0.11 | $-0.11 | ||
| Q4 24 | $0.86 | — | ||
| Q3 24 | $0.20 | $-0.20 | ||
| Q2 24 | $0.20 | $-0.19 | ||
| Q1 24 | $0.10 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $34.1M |
| Total DebtLower is stronger | — | $547.3M |
| Stockholders' EquityBook value | $1.2B | $96.9M |
| Total Assets | $1.6B | $1.4B |
| Debt / EquityLower = less leverage | — | 5.65× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | $34.1M | ||
| Q2 25 | $253.6M | $8.5M | ||
| Q1 25 | $217.7M | $48.9M | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | $181.9M | ||
| Q2 24 | $177.1M | $219.6M | ||
| Q1 24 | $204.7M | $249.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | $547.3M | ||
| Q2 25 | — | $591.2M | ||
| Q1 25 | — | $603.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $602.3M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $96.9M | ||
| Q2 25 | $822.4M | $183.9M | ||
| Q1 25 | $765.2M | $201.9M | ||
| Q4 24 | $732.8M | — | ||
| Q3 24 | $577.2M | $538.7M | ||
| Q2 24 | $516.7M | $561.6M | ||
| Q1 24 | $464.0M | $582.3M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $976.9M | $615.0M | ||
| Q2 24 | $914.1M | $644.4M | ||
| Q1 24 | $855.1M | $670.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.65× | ||
| Q2 25 | — | 3.21× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $63.9M |
| Free Cash FlowOCF − Capex | — | $55.0M |
| FCF MarginFCF / Revenue | — | 26.1% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-42.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $63.9M | ||
| Q2 25 | $64.0M | $33.4M | ||
| Q1 25 | $20.3M | $-44.8M | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $63.2M | $-28.4M | ||
| Q2 24 | $25.0M | $-28.0M | ||
| Q1 24 | $29.1M | $-16.2M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $55.0M | ||
| Q2 25 | — | $10.6M | ||
| Q1 25 | — | $-74.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | $-34.0M | ||
| Q2 24 | — | $-35.6M | ||
| Q1 24 | — | $-37.7M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | 26.1% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | -138.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 54.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |
